9258 Wealth Management, LLC Biogen Inc. Transaction History

9258 Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$268.85 - $341.04 $194,109 - $246,230	-722 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $158,883 - $219,538	722 New	722 $214,000
Q1 2019 May 07, 2019	SELL	$216.71 - $338.96 $169,033 - $264,388	-780 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $217,230 - $275,145	780 New	780 $235,000

1,022

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 9258 Wealth Management, LLC with notifications on news.